Home HCP ALL

 

Xatmep: The first and only FDA-approved methotrexate oral solution for the treatment of ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) in pediatric patients.


  • Assured efficacy delivered with consistent potency.1
  • The first and only FDA-approved methotrexate oral solution for ALL.
  • Oral solution provides consistent stability when stored as directed.2
  • No compounding or crushing tablets necessary.
  • No methotrexate injections necessary.
  • Body surface area-based dosing.

For information on the treatment of ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), click the appropriate option below, certifying your are either a healthcare provider or a patient or caregiver in the United States.


For information on the treatment of POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (pJIA), click the appropriate option below, certifying your are either a healthcare provider or a patient or caregiver in the United States.